NEOZOTAC: Efficacy results from a phase III randomized trial with neoadjuvant chemotherapy (TAC) with or without zoledronic acid for patients with HER2-negative large resectable or stage II or III breast cancer (BC)-A Dutch Breast Cancer Trialists' Group (BOOG) study

Charehbili, A.; Ven, S. van de; Liefers, G.J.; Smit, V.T.H.B.M.; Putter, H.; Heijns, J.B.; ... ; Nortier, J.W.R. (2013)

Article / Letter to editor

• All authors: Charehbili, A.; Ven, S. van de; Liefers, G.J.; Smit, V.T.H.B.M.; Putter, H.; Heijns, J.B.; Warmerdam, L. van; Kessels, L.; Dercksen, W.; Pepels, M.J.; Maartense, E.; Laarhoven, H.W.M. van; Vriens, B.; Wasser, M.N.; Hamdy, N.A.T.; Kranenbarg, E.M.K.; Leeuwen-Stok, E. van; Velde, C.J.H. van de; Kroep, J.R.; Nortier, J.W.R.
• Date: 2013-05-20
• Journal: Journal of Clinical Oncology
• Volume: 31
• Issue: 15